{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19917107", "DateCompleted": {"Year": "2010", "Month": "03", "Day": "11"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2009", "Month": "11", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1186/1472-6882-9-44"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2009", "Month": "Nov", "Day": "16"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Interleukin-6 and Cyclooxygenase-2 downregulation by fatty-acid fractions of Ranunculus constantinopolitanus.", "Pagination": {"StartPage": "44", "MedlinePgn": "44"}, "Abstract": {"AbstractText": ["Medicinal plants represent alternative means for the treatment of several chronic diseases, including inflammation. The genus Ranunculus, a representative of the Ranunculaceae family, has been reported to possess anti-inflammatory, analgesic, antiviral, antibacterial, antiparasitic and antifungal activities, possibly due to the presence of anemonin and other. Different studies have shown the occurrence of unusual fatty acids (FAs) in Ranunculaceae; however, their therapeutic role has not been investigated. The purpose of this study is to characterize potential anti-inflammatory bioactivities in Ranunculus constantinopolitanus D'Urv., traditionally used in Eastern Mediterranean folk medicine.", "The aerial part of R. constantinopolitanus was subjected to methanol (MeOH) extraction and solvent fractionation. The bioactive fraction (I.2) was further fractionated using column chromatography, and the biologically active subfraction (Y2+3) was identified using infrared (IR) spectroscopy, nuclear magnetic resonance (NMR) and gas chromatography-mass spectrometry (GC-MS). The effects of I.2 and Y2+3 on cell viability were studied in mouse mammary epithelial SCp2 cells using trypan blue exclusion method. To study the anti-inflammatory activities of I.2 and Y2+3, their ability to reduce interleukin (IL)-6 levels was assessed in endotoxin (ET)-stimulated SCp2 cells using enzyme-linked immunosorbent assay (ELISA). In addition, the ability of Y2+3 to reduce cyclooxygenase (COX)-2 expression was studied in IL-1-treated mouse intestinal epithelial Mode-K cells via western blotting. Data were analyzed by one-way analysis of variance (ANOVA), Student-Newman-Keuls (SNK), Tukey HSD, two-sample t-test and Dunnett t-tests for multiple comparisons.", "The chloroform fraction (I.2) derived from crude MeOH extract of the plant, in addition to Y2+3, a FA mix isolated from this fraction and containing palmitic acid, C18:2 and C18:1 isomers and stearic acid (1:5:8:1 ratio), reduced ET-induced IL-6 levels in SCp2 cells without affecting cell viability or morphology. When compared to fish oil, conjugated linoleic acid (CLA) and to individual FAs as palmitic, linoleic, oleic and stearic acid or to a mix of these FAs (1:5:8:1 ratio), Y2+3 exhibited higher potency in reducing ET-induced IL-6 levels within a shorter period of time. Y2+3 also reduced COX-2 expression in IL-1-treated Mode-K cells.", "Our studies demonstrate the existence of potential anti-inflammatory bioactivities in R. constantinopolitanus and attribute them to a FA mix in this plant."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, American University of Beirut, Lebanon. sff07@aub.edu.lb"}], "Identifier": [], "LastName": "Fostok", "ForeName": "Sabreen F", "Initials": "SF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ezzeddine", "ForeName": "Rima A", "Initials": "RA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Homaidan", "ForeName": "Fadia R", "Initials": "FR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Al-Saghir", "ForeName": "Jamal A", "Initials": "JA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Salloum", "ForeName": "Ralph G", "Initials": "RG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Saliba", "ForeName": "Najat A", "Initials": "NA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Talhouk", "ForeName": "Rabih S", "Initials": "RS"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Endotoxins"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Analysis of Variance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": [], "DescriptorName": "Down-Regulation"}, {"QualifierName": [], "DescriptorName": "Endotoxins"}, {"QualifierName": [], "DescriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"QualifierName": ["drug effects"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Fatty Acids"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Interleukin-1"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Plant Components, Aerial"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ranunculus"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bendyk A, Marino V, Zilm PS, Howe P, Bartold PM. Effect of dietary omega-3 polyunsaturated fatty acids on experimental periodontitis in the mouse. J Periodontal Res. 2009;44:211\u2013216. doi: 10.1111/j.1600-0765.2008.01108.x.", "ArticleIdList": ["10.1111/j.1600-0765.2008.01108.x", "19210341"]}, {"Citation": "Changhua L, Jindong Y, Defa L, Lidan Z, Shiyan Q, Jianjun X. Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J Nutr. 2005;135:239\u2013244.", "ArticleIdList": ["15671220"]}, {"Citation": "Du C, Fujii Y, Ito M, Harada M, Moriyama E, Shimada R, Ikemoto A, Okuyama H. Dietary polyunsaturated fatty acids suppress acute hepatitis, alter gene expression and prolong survival of female Long-Evans Cinnamon rats, a model of Wilson disease. J Nutr Biochem. 2004;15:273\u2013280. doi: 10.1016/j.jnutbio.2003.11.005.", "ArticleIdList": ["10.1016/j.jnutbio.2003.11.005", "15135151"]}, {"Citation": "Jaudszus A, Krokowski M, M\u00f6ckel P, Darcan Y, Avagyan A, Matricardi P, Jahreis G, Hamelmann E. Cis-9,trans-11-conjugated linoleic acid inhibits allergic sensitization and airway inflammation via a PPARgamma-related mechanism in mice. J Nutr. 2008;138:1336\u20131342.", "ArticleIdList": ["18567757"]}, {"Citation": "Sadeghi S, Wallace FA, Calder PC. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology. 1999;96:404\u2013410. doi: 10.1046/j.1365-2567.1999.00701.x.", "ArticleIdList": ["10.1046/j.1365-2567.1999.00701.x", "PMC2326770", "10233721"]}, {"Citation": "Sane S, Baba M, Kusano C, Shirao K, Andoh T, Kamada T, Aikou T. Eicosapentaenoic acid reduces pulmonary edema in endotoxemic rats. J Surg Res. 2000;93:21\u201327. doi: 10.1006/jsre.2000.5960.", "ArticleIdList": ["10.1006/jsre.2000.5960", "10945939"]}, {"Citation": "Calder PC. Polyunsaturated fatty acids and inflammation. Biochem Soc Trans. 2005;33:423\u2013427. doi: 10.1042/BST0330423.", "ArticleIdList": ["10.1042/BST0330423", "15787620"]}, {"Citation": "Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885\u2013897. doi: 10.1002/mnfr.200700289.", "ArticleIdList": ["10.1002/mnfr.200700289", "18504706"]}, {"Citation": "O'Shea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr. 2004;79(Suppl 6):1199\u20131206.", "ArticleIdList": ["15159257"]}, {"Citation": "Zainal Z, Longman AJ, Hurst S, Duggan K, Caterson B, Hughes CE, Harwood JL. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthr Cartilage. 2009;17:882\u2013891.", "ArticleIdList": ["19217322"]}, {"Citation": "Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother. 2002;56:388\u2013396. doi: 10.1016/S0753-3322(02)00256-1.", "ArticleIdList": ["10.1016/S0753-3322(02)00256-1", "12442911"]}, {"Citation": "Nies LK, Cymbala AA, Kasten SL, Lamprecht DG, Olson KL. Complementary and alternative therapies for the management of dyslipidemia. Ann Pharmacother. 2006;40:1984\u20131992. doi: 10.1345/aph.1H040.", "ArticleIdList": ["10.1345/aph.1H040", "17047144"]}, {"Citation": "Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001;40:283\u2013298. doi: 10.1016/S0163-7827(01)00008-X.", "ArticleIdList": ["10.1016/S0163-7827(01)00008-X", "11412893"]}, {"Citation": "Zulet MA, Marti A, Parra MD, Martinez JA. Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. J Physiol Biochem. 2005;61:483\u2013494. doi: 10.1007/BF03168454.", "ArticleIdList": ["10.1007/BF03168454", "16440602"]}, {"Citation": "Barbour EK, Al Sharif M, Sagherian VK, Habre AN, Talhouk RS, Talhouk SN. Screening of selected indigenous plants of Lebanon for antimicrobial activity. J Ethnopharmacol. 2004;93:1\u20137. doi: 10.1016/j.jep.2004.02.027.", "ArticleIdList": ["10.1016/j.jep.2004.02.027", "15182897"]}, {"Citation": "Cao BJ, Meng QY, Ji N. Analgesic and anti-inflammatory effects of Ranunculus japonicus extract. Planta Med. 1992;58:496\u2013498. doi: 10.1055/s-2006-961534.", "ArticleIdList": ["10.1055/s-2006-961534", "1484887"]}, {"Citation": "Li H, Zhou C, Pan Y, Gao X, Wu X, Bai H, Zhou L, Chen Z, Zhang S, Shi S, Luo J, Xu J, Chen L, Zheng X, Zhao Y. Evaluation of antiviral activity of compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus. Planta Med. 2005;71:1128\u20131133. doi: 10.1055/s-2005-873169.", "ArticleIdList": ["10.1055/s-2005-873169", "16395649"]}, {"Citation": "Mares D. Antimicrobial activity of protoanemonin, a lactone from ranunculaceous plants. Mycopathologia. 1987;98:133\u2013140. doi: 10.1007/BF00437648.", "ArticleIdList": ["10.1007/BF00437648", "3587338"]}, {"Citation": "Prieto JM, Recio MC, Giner RM, M\u00e1\u00f1ez S, R\u00edos JL. Pharmacological approach to the pro- and anti-inflammatory effects of Ranunculus sceleratus L. J Ethnopharmacol. 2003;89:131\u2013137. doi: 10.1016/S0378-8741(03)00271-X.", "ArticleIdList": ["10.1016/S0378-8741(03)00271-X", "14522444"]}, {"Citation": "Schinella GR, Tournier HA, Prieto JM, Rios JL, Buschiazzo H, Zaidenberg A. Inhibition of Trypanosoma cruzi growth by medical plant extracts. Fitoterapia. 2002;73:569\u2013575. doi: 10.1016/S0367-326X(02)00246-0.", "ArticleIdList": ["10.1016/S0367-326X(02)00246-0", "12490214"]}, {"Citation": "Duan H, Zhang Y, Xu J, Qiao J, Suo Z, Hu G, Mu X. Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells. J Ethnopharmacol. 2006;104:362\u2013366. doi: 10.1016/j.jep.2005.09.034.", "ArticleIdList": ["10.1016/j.jep.2005.09.034", "16257161"]}, {"Citation": "Lee TH, Huang NK, Lai TC, Yang AT, Wang GJ. Anemonin, from Clematis crassifolia, potent and selective inducible nitric oxide synthase inhibitor. J Ethnopharmacol. 2008;116:518\u2013527. doi: 10.1016/j.jep.2007.12.019.", "ArticleIdList": ["10.1016/j.jep.2007.12.019", "18281171"]}, {"Citation": "Martin ML, Ort\u00edz de Urbina AV, Montero MJ, Carr\u00f3n R, San Rom\u00e1n L. Pharmacologic effects of lactones isolated from Pulsatilla alpina subsp. apiifolia. J Ethnopharmacol. 1988;24:185\u2013191. doi: 10.1016/0378-8741(88)90150-X.", "ArticleIdList": ["10.1016/0378-8741(88)90150-X", "3267028"]}, {"Citation": "Saliba NA, Dakdouki S, Homeidan F, Kogan J, Bouhadir K, Talhouk S, Talhouk R. Bio-guided identification of an anti-inflammatory guaianolide from Centaurea ainetensis. Pharm Biol. 2009;47:701\u2013707. doi: 10.1080/13880200902933021.", "ArticleIdList": ["10.1080/13880200902933021"]}, {"Citation": "Homaidan FR, Chakroun I, El-Sabban ME. Regulation of nuclear factor-kappaB in intestinal epithelial cells in a cell model of inflammation. Mediators Inflamm. 2003;12:277\u2013283. doi: 10.1080/09629350310001619681.", "ArticleIdList": ["10.1080/09629350310001619681", "PMC1781626", "14760934"]}, {"Citation": "Safieh-Garabedian B, Mouneimne GM, El-Jouni W, Khattar M, Talhouk R. The effect of endotoxin on functional parameters of mammary CID-9 cells. Reproduction. 2004;127:397\u2013406. doi: 10.1530/rep.1.00135.", "ArticleIdList": ["10.1530/rep.1.00135", "15016959"]}, {"Citation": "Talhouk RS, Karam C, Fostok S, El-Jouni W, Barbour EK. Anti-inflammatory bioactivities in plant extracts. J Med Food. 2007;10:1\u201310. doi: 10.1089/jmf.2005.055.", "ArticleIdList": ["10.1089/jmf.2005.055", "17472460"]}, {"Citation": "Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8(Suppl 2):3. doi: 10.1186/ar1917.", "ArticleIdList": ["10.1186/ar1917", "PMC3226076", "16899107"]}, {"Citation": "Aitzetmuller K. An unusual fatty acid pattern in Eranthis seed oil. Lipids. 1996;31:201\u2013205. doi: 10.1007/BF02522621.", "ArticleIdList": ["10.1007/BF02522621", "8835409"]}, {"Citation": "Chen J, Yao C, Xia LM, Ouyang PK. [Determination of fatty acids and organic acids in Ranunculus ternatus Thunb using GC-MS] Guang Pu Xue Yu Guang Pu Fen Xi. 2006;26:1550\u20131552.", "ArticleIdList": ["17058970"]}, {"Citation": "Spencer GF, Kleiman R, Earle FR, Wolff IA. Unusual olefinic fatty acids in seed oils from two genera in the Ranunculaceae. Lipids. 1970;5:277\u2013278. doi: 10.1007/BF02532479.", "ArticleIdList": ["10.1007/BF02532479"]}, {"Citation": "Garg S, Talwar GP, Upadhyay SN. Immunocontraceptive activity guided fractionation and characterization of active constituents of neem (Azadirachta indica) seed extracts. J Ethnopharmacol. 1998;60:235\u2013246. doi: 10.1016/S0378-8741(97)00157-8.", "ArticleIdList": ["10.1016/S0378-8741(97)00157-8", "9613837"]}, {"Citation": "Lo CJ, Chiu KC, Fu M, Lo R, Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res. 1999;82:216\u2013221. doi: 10.1006/jsre.1998.5524.", "ArticleIdList": ["10.1006/jsre.1998.5524", "10090832"]}, {"Citation": "Puglia C, Tropea S, Rizza L, Santagati NA, Bonina F. In vitro percutaneous absorption studies and in vivo evaluation of anti-inflammatory activity of essential fatty acids (EFA) from fish oil extracts. Int J Pharm. 2005;299:41\u201348. doi: 10.1016/j.ijpharm.2005.04.031.", "ArticleIdList": ["10.1016/j.ijpharm.2005.04.031", "15979259"]}, {"Citation": "Shen CL, Dunn DM, Henry JH, Li Y, Watkins BA. Decreased production of inflammatory mediators in human osteoarthritic chondrocytes by conjugated linoleic acids. Lipids. 2004;39:161\u2013166.", "ArticleIdList": ["15134143"]}, {"Citation": "Tappia PS, Grimble RF. Complex modulation of cytokine induction by endotoxin and tumour necrosis factor from peritoneal macrophages of rats by diets containing fats of different saturated, monounsaturated and polyunsaturated fatty acid composition. Clin Sci (Lond) 1994;87:173\u2013178.", "ArticleIdList": ["7924162"]}, {"Citation": "Belluzzi A. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment. Eur Rev Med Pharmacol Sci. 2004;8:225\u2013229.", "ArticleIdList": ["15638235"]}, {"Citation": "Wild GE, Drozdowski L, Tartaglia C, Clandinin MT, Thomson AB. Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical. World J Gastroenterol. 2007;13:1\u20137.", "ArticleIdList": ["PMC4065867", "17206749"]}, {"Citation": "Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr. 2006;25:454\u2013465. doi: 10.1016/j.clnu.2005.12.008.", "ArticleIdList": ["10.1016/j.clnu.2005.12.008", "16698153"]}, {"Citation": "Al-Saghir J, Al-Ashi R, Salloum R, Saliba NA, Talhouk RS, Homaidan FR. Anti-inflammatory properties of Salograviolide A purified from Lebanese plant Centaurea ainetensis. BMC Complement Altern Med. p. 36.", "ArticleIdList": ["10.1186/1472-6882-9-36", "PMC2761300", "19775456"]}, {"Citation": "Post GE. In: Flora of Syria, Palestine and Sinai. 2. Dinsmore JE, editor. Vol. 1. Beirut: American Press; 1932. The plants; p. 14."}]}], "History": [{"Year": "2009", "Month": "8", "Day": "5"}, {"Year": "2009", "Month": "11", "Day": "16"}, {"Year": "2009", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2009", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2009", "Month": "11", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["19917107", "PMC2784432", "10.1186/1472-6882-9-44", "1472-6882-9-44"]}}], "PubmedBookArticle": []}